On March 24, 2020 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense repored that Shawn Iadonato, Kineta Chief Executive Officer, will present an overview of the company at the upcoming Solebury Trout Virtual Investor Conference (Press release, Kineta, MAR 24, 2020, View Source;utm_medium=rss&utm_campaign=kineta-invited-to-participate-solebury-trout [SID1234555825]). The 25 minute presentation includes an interactive Q&A with participants prompted to submit questions electronically. Details for the virtual presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Thursday, March 26th, 2020

Time: 2:30 PM Eastern Time / 11:30 AM Pacific Time